Innophos Reports Net Sales of $209 Million in Q4
date:Feb 16, 2013
as the Asia Pacific region. Our latest acquisition, Triarco, was completed on December 31st, and I believe Triarcos botanical and enzyme based ingredients business will prove highly complementary to the two mineral ingredients businesses, Kelatron and AMT, that we acquired in late 2011 and mid-2012. Through these acquisitions we have built a strong platform for future growth that will also support growth in our Specialty Phosphate product range.

Mr. Gress concluded, Looking ahead to the coming
7/11 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/17 19:50